The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Infections in Cancer Patients with Solid Tumors: A Review
Open accessAbstract
Solid tumors are much more common than hematologic malignancies. Although severe and prolonged neutropenia is uncommon, several factors increase the risk of infection in patients with solid tumors, and the presence of multiple risk factors in the same patient is not uncommon. These include obstruction (most often caused by progression of the tumor), disruption of natural anatomic barriers such as the skin and mucosal surfaces, and treatment-related factors such as chemotherapy, radiation, diagnostic and/or therapeutic surgical procedures, and the increasing use of medical devices such as various catheters, stents, and prostheses. Common sites of infection include the skin and skin structures (including surgical site infections), the bloodstream (including infections associated with central venous catheters), the lungs, the hepato-biliary and intestinal tracts, and the urinary tract, and include distinct clinical syndromes such as post-obstructive pneumonia, obstructive uropathy, and neutropenic enterocolitis. The epidemiology of most of these infections is changing with resistant organisms [MRSA, Pseudomonas aeruginosa, extended spectrum beta-lactamase (ESBL)-producing organisms] being isolated more often than in the past. Polymicrobial infections now predominate when deep tissue sites are involved. Conservative management of most of these infections (antibiotics, fluid and electrolyte replacement, bowel rest when needed) is generally effective, with surgical intervention being reserved for the drainage of deep abscesses, or to deal with complications such as intestinal obstruction or hemorrhage. Infected prostheses often need to be removed. Reactivation of certain viral infections (HBV, HCV, and occasionally CMV) has become an important issue, and screening, prevention and treatment strategies are being developed. Infection prevention, infection control, and antimicrobial stewardship are important strategies in the overall management of infections in patients with solid tumors. Occasionally, infections mimic solid tumors and cause diagnostic and therapeutic challenges.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R. L., Miller, K. D., & Jemal, A. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21332 · Cited by 16,003
Freifeld, A. G., Bow, E. J., Sepkowitz, K. A., Boeckh, M. J., Ito, J. I., Mullen, C. A., Raad, I. I., Rolston, K. V., Young, J.-A. H., & Wingard, J. R. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir073 · Cited by 3,463
Self-citationGuideline for Prevention of Surgical Site Infection, 1999
Mangram, A. J., Horan, T. C., Pearson, M. L., Silver, L. C., & Jarvis, W. R. (1999) · American Journal of Infection Control · doi:10.1016/s0196-6553(99)70088-x · Cited by 2,881
Mangram, A. J., Horan, T. C., Pearson, M. L., Silver, L. C., & Jarvis, W. R. (1999) · PubMed · Cited by 2,783
Klastersky, J., Paesmans, M., Rubenstein, E. B., Boyer, M., Elting, L., Feld, R., Gallagher, J., Herrstedt, J., Rapoport, B., Rolston, K., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.16.3038 · Cited by 1,171
Self-citationEpidemiology of viral hepatitis and HIV co-infection
Alter, M. J. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2005.11.004 · Cited by 1,012
Weinbaum, C. M., Mast, E. E., & Ward, J. W. (2009) · Hepatology · doi:10.1002/hep.22882 · Cited by 815
Host and Pathogen Factors for Clostridium difficile Infection and Colonization
Loo, V. G., Bourgault, A.-M., Poirier, L., Lamothe, F., Michaud, S., Turgeon, N., Toye, B., Beaudoin, A., Frost, E. H., Gilca, R., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1012413 · Cited by 797
Kelly, C. R., Khoruts, A., Staley, C., Sadowsky, M. J., Abd, M., Alani, M., Bakow, B., Curran, P., McKenney, J., Tisch, A., et al. (2016) · Annals of Internal Medicine · doi:10.7326/m16-0271 · Cited by 613
Flowers, C. R., Seidenfeld, J., Bow, E. J., Karten, C., Gleason, C., Hawley, D. K., Kuderer, N. M., Langston, A. A., Marr, K. A., Rolston, K. V. I., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.45.8661 · Cited by 448
Self-citationBaden, L. R., Swaminathan, S., Angarone, M., Blouin, G., Camins, B. C., Casper, C., Cooper, B., Dubberke, E. R., Engemann, A. M., Freifeld, A. G., et al. (2016) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2016.0093 · Cited by 442
Self-citationManagement of febrile neutropenia: ESMO Clinical Practice Guidelines
de Naurois, J., Novitzky-Basso, I., Gill, M. J., Marti Marti, F., Cullen, M. H., & Roila, F. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq196 · Cited by 435
Cordeiro, P. G., Pusic, A. L., Disa, J. J., McCormick, B., & VanZee, K. (2004) · Plastic and Reconstructive Surgery · doi:10.1097/01.prs.0000105689.84930.e5 · Cited by 377
Weinbaum, C. M., Williams, I., Mast, E. E., Wang, S. A., Finelli, L., Wasley, A., Neitzel, S. M., & Ward, J. W. (2008) · PubMed · Cited by 364
The Prevalence of Hepatitis B Virus Infection in the United States in the Era of Vaccination
Wasley, A., Kruszon‐Moran, D., Kuhnert, W., Simard, E. P., Finelli, L., McQuillan, G., & Bell, B. (2010) · The Journal of Infectious Diseases · doi:10.1086/653622 · Cited by 351
Global Burden of Hepatitis C: Considerations for Healthcare Providers in the United States
Averhoff, F. M., Glass, N., & Holtzman, D. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis361 · Cited by 318
Cordeiro, P. G., & McCarthy, C. M. (2006) · Plastic & Reconstructive Surgery · doi:10.1097/01.prs.0000232397.14818.0e · Cited by 267
Cartoni, C., Dragoni, F., Micozzi, A., Pescarmona, E., Mecarocci, S., Chirletti, P., Petti, M. C., Meloni, G., & Mandelli, F. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.3.756 · Cited by 192
Epidemiology and natural history of hepatitis C virus infection.
Lee, M., Yang, H., Yuan, Y., L'Italien, G. J., & Chen, C. (2014) · PubMed · doi:10.3748/wjg.v20.i28.9270 · Cited by 186
Paul, S., Saxena, A., Terrin, N., Viveiros, K., Balk, E. M., & Wong, J. B. (2016) · Annals of Internal Medicine · doi:10.7326/m15-1121 · Cited by 177
Immunosuppression and HBV Reactivation
Shibolet, O., & Shouval, D. (2013) · Seminars in Liver Disease · doi:10.1055/s-0033-1345722 · Cited by 176
Polymicrobial Infection in Patients with Cancer: An Underappreciated and Underreported Entity
Rolston, K. V. I., Bodey, G. P., & Safdar, A. (2007) · Clinical Infectious Diseases · doi:10.1086/518873 · Cited by 166
Self-citationAriyan, S., Martin, J., Lal, A., Cheng, D., Borah, G. L., Chung, K. C., Conly, J., Havlik, R., Lee, W. P. A., McGrath, M. H., et al. (2015) · Plastic and Reconstructive Surgery · doi:10.1097/prs.0000000000001265 · Cited by 159
Colitis associated with docetaxel-based chemotherapy in patients with metastatic breast cancer
Ibrahim, N. K., Şahin, A. A., DuBrow, R. A., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(99)06195-4 · Cited by 141
New Trends in Patient Management: Risk-Based Therapy for Febrile Patients with Neutropenia
Rolston, K. V. I. (1999) · Clinical Infectious Diseases · doi:10.1086/598624 · Cited by 123
Self-citationMarín, M., Gudiol, C., Ardanuy, C., García‐Vidal, C., Calvo, M., Arnán, M., & Carratalà, J. (2014) · Journal of Infection · doi:10.1016/j.jinf.2014.05.018 · Cited by 122
Bloodstream infections in patients with solid tumors
Gudiol, C., Aguado, J. M., & Carratalà, J. (2016) · Virulence · doi:10.1080/21505594.2016.1141161 · Cited by 121
The spectrum of pulmonary infections in cancer patients
Rolston, K. V. I. (2001) · Current Opinion in Oncology · doi:10.1097/00001622-200107000-00002 · Cited by 107
Self-citationMarín, M., Gudiol, C., García‐Vidal, C., Ardanuy, C., & Carratalà, J. (2014) · Medicine · doi:10.1097/md.0000000000000026 · Cited by 106
Cornely, O. A., Nathwani, D., Ivanescu, C., Odufowora-Sita, O., Retsa, P., & Odeyemi, I. A. O. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku261 · Cited by 104
Risk Assessment and Treatment of Low-Risk Patients with Febrile Neutropenia
Kern, W. V. (2006) · Clinical Infectious Diseases · doi:10.1086/499352 · Cited by 87
Barr, S., Topps, A., Barnes, N. L. P., Henderson, J. R., Hignett, S., Teasdale, R. L., McKenna, A. V., Harvey, J., & Kirwan, C. (2016) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2016.02.240 · Cited by 85
Breast Implant Infections: Is Cefazolin Enough?
Feldman, E. M., Kontoyiannis, D. P., Sharabi, S. E., Lee, E. W., Kaufman, Y., & Heller, L. (2010) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0b013e3181e5f7ff · Cited by 81
Bahu, R. R., Chaftari, A., Hachem, R. Y., Ahrar, K., Shomali, W. E., Zakhem, A. E., Jiang, Y., Shuaibi, M. A., & RAAD, I. I. (2012) · The Journal of Urology · doi:10.1016/j.juro.2012.08.094 · Cited by 73
Torres, H. A., Kontoyiannis, D. P., Bodey, G. P., Adachi, J. A., Luna, M. A., Tarrand, J. J., Nogueras, G. M., RAAD, I. I., & Chemaly, R. F. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.07.011 · Cited by 56
Avritscher, E. B. C., Cooksley, C. D., Rolston, K. V., Swint, J. M., Delclos, G. L., Franzini, L., Swisher, S. G., Walsh, G. L., Mansfield, P. F., & Elting, L. S. (2013) · Supportive Care in Cancer · doi:10.1007/s00520-013-2006-1 · Cited by 48
Self-citationHepatitis C virus reactivation in cancer patients in the era of targeted therapies
Yazıcı, O. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i22.6716 · Cited by 47
Salvaging the Infected Breast Tissue Expander: A Standardized Multidisciplinary Approach
Viola, G. M., Selber, J. C., Crosby, M. A., RAAD, I. I., Butler, C. E., Villa, M. T., Kronowitz, S. J., Clemens, M. W., Garvey, P. B., Yang, W. T., et al. (2016) · Plastic & Reconstructive Surgery Global Open · doi:10.1097/gox.0000000000000676 · Cited by 42
Breast Tissue Expander—Related Infections: Perioperative Antimicrobial Regimens
Viola, G. M., RAAD, I. I., & Rolston, K. V. I. (2013) · Infection Control and Hospital Epidemiology · doi:10.1086/674390 · Cited by 38
Self-citationInfection-related hospitalizations in breast cancer patients: Risk and impact on prognosis
Brand, J. S., Colzani, E., Johansson, A. L. V., Giesecke, J., Clements, M., Bergh, J. C. S., Hall, P. N., & Czene, K. (2016) · Journal of Infection · doi:10.1016/j.jinf.2016.04.003 · Cited by 38
Prevention and Management of Infectious Complications of Percutaneous Interventions
Huang, S. Y., Philip, A., Richter, M., Gupta, S. K., Lessne, M. L., & Kim, C. (2015) · Seminars in Interventional Radiology · doi:10.1055/s-0035-1549372 · Cited by 34
Challenges in managing hepatitis C virus infection in cancer patients
Borchardt, R. A. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i11.2771 · Cited by 32
Fujii, T., Kanda, M., Nagai, S., Suenaga, M., Takami, H., Yamada, S., Sugimoto, H., Nomoto, S., Nakao, A., & Kodera, Y. (2015) · Pancreas · doi:10.1097/mpa.0000000000000352 · Cited by 32
Fidaxomicin Therapy in Critically Ill Patients with Clostridium difficile Infection
Penziner, S., Dubrovskaya, Y., Press, R. A., & Safdar, A. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04268-14 · Cited by 31
The microbiology of postobstructive pneumonia in lung cancer patients
Hsu-Kim, C., Hoag, J. B., Cheng, G.-S., & Lund, M. E. (2013) · Journal of Bronchology & Interventional Pulmonology · doi:10.1097/lbr.0b013e31829ddf01 · Cited by 27
Huo, J. S., Smith, B. D., Giordano, S. H., Reece, G. P., & Shih, Y. T. (2016) · Breast Cancer Research and Treatment · doi:10.1007/s10549-016-3832-x · Cited by 25
Cited by
COVID-19 and Cancer: Current Challenges and Perspectives
Bakouny, Z., Hawley, J. E., Choueiri, T. K., Peters, S., Rini, B. I., Warner, J. L., & Painter, C. A. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.09.018 · Cited by 275
(2021) · doi:10.3322/caac.21697 · Cited by 201
COVID-19-Related Fear and Health-Related Safety Behavior in Oncological Patients
Musche, V., Bäuerle, A., Steinbach, J., Schweda, A., Hetkamp, M., Weismüller, B., Kohler, H., Beckmann, M., Herrmann, K., Tewes, M., et al. (2020) · Frontiers in Psychology · doi:10.3389/fpsyg.2020.01984 · Cited by 99
Bose, R. J. C., Tharmalingam, N., Garcia Marques, F. J., Sukumar, U. K., Natarajan, A., Zeng, Y., Robinson, E., Bermudez, A., Chang, E., Habte, F., et al. (2020) · ACS Nano · doi:10.1021/acsnano.0c00921 · Cited by 84
Metadata
- Authors
- Rolston, K. V. I.
- Venue
- Infectious Diseases and Therapy
- Published
- 2017-02-03
- Volume
- 6
- Issue
- 1
- Pages
- 69-83
- ISSN
- 2193-6382 (ISSN-L)
- 2193-8229
- OpenAlex
- W2585056247
- Cited by
- 334
- References
- 46
- FWCI
- 8.62
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.